Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of unusually large options trading on Thursday. Stock investors bought 10,279 put options on the stock. This represents an increase of 955% compared to the typical volume of 974 put options.
Harrow Trading Up 1.2 %
Shares of HROW stock opened at $50.37 on Friday. The company has a current ratio of 2.60, a quick ratio of 2.43 and a debt-to-equity ratio of 3.18. Harrow has a twelve month low of $7.60 and a twelve month high of $51.81. The company’s 50-day moving average price is $38.93 and its 200-day moving average price is $24.31. The stock has a market cap of $1.78 billion, a price-to-earnings ratio of -55.35 and a beta of 0.75.
Harrow (NASDAQ:HROW – Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.25) by $0.12. The business had revenue of $48.94 million during the quarter, compared to analysts’ expectations of $42.78 million. Harrow had a negative net margin of 21.78% and a negative return on equity of 40.59%. As a group, equities analysts predict that Harrow will post -0.14 earnings per share for the current year.
Institutional Investors Weigh In On Harrow
Analyst Ratings Changes
A number of brokerages have recently commented on HROW. Craig Hallum increased their target price on shares of Harrow from $45.00 to $65.00 and gave the company a “buy” rating in a research report on Friday. Lake Street Capital raised their target price on shares of Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday. Finally, B. Riley restated a “buy” rating and issued a $50.00 price target on shares of Harrow in a research report on Thursday, August 29th.
About Harrow
Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Featured Stories
- Five stocks we like better than Harrow
- Insider Trades May Not Tell You What You Think
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- ETF Screener: Uses and Step-by-Step Guide
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Harrow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow and related companies with MarketBeat.com's FREE daily email newsletter.